We are live on ! Find out more
NCM

Novare Capital Management Portfolio holdings

AUM $1.26B
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
-0.74%
1 Year Est. Return
+20.28%
3 Year Est. Return
+65.67%
5 Year Est. Return
+78.77%
10 Year Est. Return
+251.06%
AUM
$405M
AUM Growth
+$1.43M
Cap. Flow
+$5.66M
Cap. Flow %
1.4%
Top 10 Hldgs %
23.57%
Holding
117
New
4
Increased
45
Reduced
48
Closed
8

Top Sells

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$5.45M
2
VTRS icon
Viatris
VTRS
+$3.14M
3
EMCI
EMC INS Group Inc
EMCI
+$2.6M
4
EMR icon
Emerson Electric
EMR
+$1.15M
5
GPN icon
Global Payments
GPN
+$1.13M

Sector Composition

Rank Sector Weight
1 Energy 22.31%
2 Healthcare 12.71%
3 Financials 10.67%
4 Industrials 8.17%
5 Consumer Discretionary 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
26
Pfizer
PFE
$149B
$6.21M 1.53%
195,174
+6,226
+3% +$203K
JNJ icon
27
Johnson & Johnson
JNJ
$619B
$6.07M 1.5%
62,256
+3,866
+7% +$387K
APTV icon
28
Aptiv
APTV
$9.61B
$5.85M 1.44%
+68,705
New +$5.88M
MDT icon
29
Medtronic
MDT
$110B
$5.8M 1.43%
78,275
+5,481
+8% +$419K
EMCI
30
DELISTED
EMC INS Group Inc
EMCI
$5.8M 1.43%
219,652
-110,786
-34% -$2.6M
AXP icon
31
American Express
AXP
$231B
$5.39M 1.33%
69,344
+2,142
+3% +$170K
EBAY icon
32
eBay
EBAY
$48.9B
$5.38M 1.33%
212,407
-5,560
-3% -$139K
AZO icon
33
AutoZone
AZO
$50.1B
$5.24M 1.29%
7,853
+59
+0.8% +$40.4K
BNY
34
Bank of New York Mellon
BNY
$108B
$5.22M 1.29%
124,387
+9,873
+9% +$421K
DD
35
DELISTED
Du Pont De Nemours E I
DD
$5.19M 1.28%
85,527
+952
+1% +$64.1K
MRO
36
DELISTED
Marathon Oil Corporation
MRO
$5.12M 1.26%
192,943
+10,350
+6% +$292K
MDRX
37
DELISTED
Veradigm Inc. Common Stock
MDRX
$5.1M 1.26%
372,695
+17,295
+5% +$234K
NGLS
38
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
$5.04M 1.24%
130,445
-1,571
-1% -$68K
SLB icon
39
SLB Ltd
SLB
$76.5B
$5M 1.23%
58,040
-2,295
-4% -$207K
EEP
40
DELISTED
Enbridge Energy Partners
EEP
$4.96M 1.22%
148,789
-2,950
-2% -$109K
CVX icon
41
Chevron
CVX
$371B
$4.8M 1.18%
49,716
-160
-0.3% -$16.8K
ASH icon
42
Ashland
ASH
$3.32B
$4.7M 1.16%
78,868
-204
-0.3% -$12.7K
DG icon
43
Dollar General
DG
$28.1B
$4.7M 1.16%
60,390
+11,980
+25% +$904K
PEP icon
44
PepsiCo
PEP
$189B
$4.48M 1.1%
47,957
+2,479
+5% +$237K
GOOG icon
45
Alphabet (Google) Class C
GOOG
$4.36T
$4.43M 1.09%
164,220
+15,352
+10% +$411K
FITB
46
Fifth Third Bancorp
FITB
$51.7B
$4.25M 1.05%
204,312
-54,070
-21% -$1.1M
WMB icon
47
Williams Companies
WMB
$87.8B
$4.18M 1.03%
72,925
+7,730
+12% +$398K
EZU icon
48
iShare MSCI Eurozone ETF
EZU
$9.84B
$4.17M 1.03%
+111,145
New +$4.39M
BEAV
49
DELISTED
B/E Aerospace Inc
BEAV
$4.03M 0.99%
+73,340
New +$4.37M
PARA
50
DELISTED
Paramount Global Class B
PARA
$3.88M 0.96%
69,927
+19,560
+39% +$1.18M

Similar funds

Novare Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Novare Capital Management held 117 positions worth $405M, up 0.35% from $404M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Novare Capital Management's Q2 2015 filing shows 4 new, 45 increased, 48 reduced and 8 closed positions. Its largest new stake was Aptiv: 68,705 shares worth $5.85M. The largest sale was Norfolk Southern, an estimated $5.45M.

By sector, the portfolio is most concentrated in Energy at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Novare Capital Management's largest Q2 2015 buy was Aptiv: 68,705 shares worth $5.85M.
  • Novare Capital Management added most to Vanguard FTSE Emerging Markets ETF in Q2 2015, an estimated $1.3M increase.
  • Novare Capital Management's biggest Q2 2015 reduction was Viatris, cutting an estimated $3.14M.
  • Novare Capital Management fully exited Norfolk Southern in Q2 2015, selling an estimated $5.45M.
  • Novare Capital Management's ten largest holdings make up 24% of its $405M portfolio in Q2 2015.
  • Novare Capital Management opened 4 new positions and closed 8 in Q2 2015.
  • Novare Capital Management's portfolio value rose 0.35% quarter-over-quarter to $405M.

Based on Novare Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.